453.

Catanese L, Rupprecht H, Huber TB, Lindenmeyer MT, Hengel FE, Amann K, Wendt R, Siwy J, Mischak H, Beige J.

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.

Int J Mol Sci. 2024 Mar 20;25(6):3519. doi: 10.3390/ijms25063519.

PMID: 38542491

View Abstract:  Free PMC article. Request Reprint

 

452.

Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, Catanese L, Amann K, Huber TB, Beige J, Rupprecht HD, Siwy J.

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.

Nephrol Dial Transplant. 2024 Feb 28;39(3):453-462. doi: 10.1093/ndt/gfad200.

PMID: 37697716

View Abstract:  Free PMC article. Request Reprint

 

451.

Brasseler M, Mischak H, Schanstra JP, Michel JM, Pape L, Felderhoff-Müser U.

Gestational Age-Related Urinary Peptidome Changes in Preterm and Term Born Infants.

Neonatology. 2024 Feb 21:1-9. doi: 10.1159/000535355. Online ahead of print.

PMID: 38382482

View Abstract:  Free PMC article. Request Reprint

 

450.

Yu YL, Huang QF, An DW, Raad J, Martens DS, Latosinska A, Stolarz-Skrzypek K, Van Cleemput J, Feng YQ, Mischak H, Allegaert K, Verhamme P, Janssens S, Nawrot TS, Staessen JA.

OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients.

Heliyon. 2024 Jan 20;10(2):e24867. doi: 10.1016/j.heliyon.2024.e24867. eCollection 2024 Jan 30.

PMID: 38312576

View Abstract:  Free PMC article. Request Reprint

 

449.

Mina IK, Mavrogeorgis E, Siwy J, Stojanov R, Mischak H, Latosinska A, Jankowski V.

Multiple urinary peptides display distinct sex-specific distribution.

Proteomics. 2024 Mar;24(5):e2300227. doi: 10.1002/pmic.202300227. Epub 2023 Sep 26.

PMID: 37750242

View Abstract:  Free PMC article. Request Reprint

 

448.

Ahluwalia TS, Rönkkö TKE, Eickhoff MK, Curovic VR, Siwy J, Eder S, Denicolò S, Mayer G, Mischak H, Rossing P, Persson F.

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.

Kidney Int Rep. 2023 Nov 29;9(2):334-346. doi: 10.1016/j.ekir.2023.11.020. eCollection 2024 Feb.

PMID: 38344728

View Abstract:  Free PMC article. Request Reprint

 

447.

Catanese L, Siwy J, Wendt R, Amann K, Beige J, Hendry B, Mischak H, Mullen W, Paterson I, Schiffer M, Wolf M, Rupprecht H.

Differentiating primary and secondary FSGS using non-invasive urine biomarkers.

Clin Kidney J. 2023 Dec 4;17(2):sfad296. doi: 10.1093/ckj/sfad296. eCollection 2024 Feb.

PMID: 38313685 

View Abstract:  Free PMC article. Request Reprint

 

446.

Martens DS, An DW, Yu YL, Chori BS, Wang C, Silva AI, Wei FF, Liu C, Stolarz-Skrzypek K, Rajzer M, Latosinska A, Mischak H, Staessen JA, Nawrot TS; (The FLEMENGHO Investigators).

Association of Air Pollution with a Urinary Biomarker of Biological Aging and Effect Modification by Vitamin K in the FLEMENGHO Prospective Population Study.

Environ Health Perspect. 2023 Dec;131(12):127011. doi: 10.1289/EHP13414. Epub 2023 Dec 11.

PMID: 38078706 

View Abstract:  Free PMC article. Request Reprint

 

445.

Peters B, Beige J, Siwy J, Rudnicki M, Wendt R, Ortiz A, Sanz AB, Mischak H, Reich HN, Nasic S, Mahmood D, Persson A, Fernström A, Weiner M, Stegmayr B; PersTIgAN Working Group.

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy.

Nephrol Dial Transplant. 2023 Nov 30;38(12):2826-2834. doi: 10.1093/ndt/gfad125.

PMID: 37349951 

View Abstract:  Free PMC article. Request Reprint

 

444.

Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, Siwy J, Rossing P, Mayer G, Jankowski J.

Urinary peptide analysis to predict the response to blood pressure medication.

Nephrol Dial Transplant. 2023 Oct 31:gfad223. doi: 10.1093/ndt/gfad223. Online ahead of print.

PMID: 37930730

View Abstract:  Free PMC article. Request Reprint

 

443.

Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C, Beige J, Glorieux G, Clark AL, Mullen W, Schanstra JP, Vlahou A, Rossing K, Peter K, Ortiz A, Campbell A, Persson F, Latosinska A, Mischak H, Siwy J, Jankowski J.

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.

Pharmaceuticals (Basel). 2023 Sep 14;16(9):1298. doi: 10.3390/ph16091298.

PMID: 37765106

View Abstract:  Free PMC article. Request Reprint

 

442.

Hobson S, Mavrogeorgis E, He T, Siwy J, Ebert T, Kublickiene K, Stenvinkel P, Mischak H.

Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD.

Proteomes. 2023 Aug 23;11(3):25. doi: 10.3390/proteomes11030025.

PMID: 37755704

View Abstract:  Free PMC article. Request Reprint

 

441.

Mina IK, Mavrogeorgis E, Siwy J, Stojanov R, Mischak H, Latosinska A, Jankowski V.

Multiple urinary peptides display distinct sex-specific distribution.

Proteomics. 2023 Sep 26:e2300227. doi: 10.1002/pmic.202300227. Online ahead of print.

PMID: 37750242

View Abstract:  Free PMC article. Request Reprint

 

440.

Keller F, Beige J, Siwy J, Mebazaa A, An D, Mischak H, Schanstra JP, Mokou M, Perco P, Staessen JA, Vlahou A, Latosinska A.

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios.

J Transl Med. 2023 Sep 24;21(1):663. doi: 10.1186/s12967-023-04508-6.

PMID: 37741989

View Abstract:  Free PMC article. Request Reprint

 

439.

Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, Catanese L, Amann K, Huber TB, Beige J, Rupprecht H, Siwy J.

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.

Nephrol Dial Transplant. 2023 Sep 11:gfad200. doi: 10.1093/ndt/gfad200. Online ahead of print.

PMID: 37697716

View Abstract:  Free PMC article. Request Reprint

 

438.

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thöni S, Mayer G, Mischak H, Vlahou A, Jankowski V.

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment.

Int J Mol Sci. 2023 Aug 31;24(17):13540. doi: 10.3390/ijms241713540.

PMID: 37686344

View Abstract:  Free PMC article. Request Reprint

 

437.

de Beer D, Mels CM, Schutte AE, Delles C, Mary S, Mullen W, Mischak H, Kruger R.

Urinary Peptidomics and Pulse Wave Velocity: The African-PREDICT Study.

J Proteome Res. 2023 Oct 6;22(10):3282-3289. doi: 10.1021/acs.jproteome.3c00347. Epub 2023 Sep 9.

PMID: 37688558

View Abstract:  Free PMC article. Request Reprint

 

436.

Boutin L, Latosinska A, Mischak H, Deniau B, Asakage A, Legrand M, Gayat E, Mebazaa A, Chadjichristos CE, Depret F.

Subclinical and clinical acute kidney injury share similar urinary peptide signatures and prognosis.

Intensive Care Med. 2023 Oct;49(10):1191-1202. doi: 10.1007/s00134-023-07198-2. Epub 2023 Sep 5.

PMID: 37670154

View Abstract:  Free PMC article. Request Reprint

 

435.

Mischak H.

Further comments on 'A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension'.

J Hypertens. 2023 Oct 1;41(10):1667. doi: 10.1097/HJH.0000000000003524.

PMID: 37642595

View Abstract:  Free PMC article. Request Reprint

 

434.

Mischak H.

Comment on 'A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension' by Lin et al.

J Hypertens. 2023 Oct 1;41(10):1666. doi: 10.1097/HJH.0000000000003489.

PMID: 37642594

View Abstract:  Free PMC article. Request Reprint

 

433.

Mina IK, Mavrogeorgis E, Siwy J, Stojanov R, Mischak H, Latosinska A, Jankowski V.

Multiple urinary peptides display distinct sex-specific distribution.

Proteomics. 2023 Sep 26:e2300227. doi: 10.1002/pmic.202300227.

PMID: 37750242

View Abstract:  Free PMC article. Request Reprint

 

432.

Keller F, Beige J, Siwy J, Mebazaa A, An D, Mischak H, Schanstra JP, Mokou M, Perco P, Staessen JA, Vlahou A, Latosinska A.

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios.

J Transl Med. 2023 Sep 24;21(1):663. doi: 10.1186/s12967-023-04508-6.

PMID: 37741989

View Abstract:  Free PMC article. Request Reprint

 

431.

Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C, Beige J, Glorieux G, Clark AL, Mullen W, Schanstra JP, Vlahou A, Rossing K, Peter K, Ortiz A, Campbell A, Persson F, Latosinska A, Mischak H, Siwy J, Jankowski J.

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.

Pharmaceuticals (Basel). 2023 Sep 14;16(9):1298. doi: 10.3390/ph16091298.

PMID: 37765106

View Abstract:  Free PMC article. Request Reprint

 

430.

Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, Catanese L, Amann K, Huber TB, Beige J, Rupprecht H, Siwy J.

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.

Nephrol Dial Transplant. 2023 Sep 11:gfad200. doi: 10.1093/ndt/gfad200.

PMID: 37697716

View Abstract:  Free PMC article. Request Reprint

 

429.

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thöni S, Mayer G, Mischak H, Vlahou A, Jankowski V.

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment.

Int J Mol Sci. 2023 Aug 31;24(17):13540. doi: 10.3390/ijms241713540.

PMID: 37686344

View Abstract:  Free PMC article. Request Reprint

 

428.

Hobson S, Mavrogeorgis E, He T, Siwy J, Ebert T, Kublickiene K, Stenvinkel P, Mischak H.

Proteomes. 2023 Aug 23;11(3):25. doi: 10.3390/proteomes11030025.

PMID: 37755704

View Abstract:  Free PMC article. Request Reprint

427.

Latosinska A, Frantzi M, Siwy J.

Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation​.

Mass Spectrom Rev. 2023 Jun 26. doi: 10.1002/mas.21854. Online ahead of print.

PMID: 37357849

View Abstract:  Free PMC article. Request Reprint

 

426.

Marx D, Anglicheau D, Caillard S, Moulin B, Kochman A, Mischak H, Latosinska A, Bienaimé F, Prié D, Marquet P, Perrin P, Gwinner W, Metzger J.

Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients.

Proteomics Clin Appl. 2023 Jun 27:e2200118. doi: 10.1002/prca.202200118. Online ahead of print.

PMID: 37365945

View Abstract:  Free PMC article. Request Reprint

 

425.

Peters B, Beige J, Siwy J, Rudnicki M, Wendt R, Ortiz A, Sanz AB, Mischak H, Reich HN, Nasic S, Mahmood D, Persson A, Fernström A, Weiner M, Stegmayr B; PersTIgAN working group.

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy.

Nephrol Dial Transplant. 2023 Jun 22:gfad125. doi: 10.1093/ndt/gfad125. Online ahead of print.

PMID: 37349951

View Abstract:  Free PMC article. Request Reprint

 

424.

Chori BS, An DW, Martens DS, Yu YL, Gilis-Malinowska N, Abubakar SM, Ibrahim EA, Ajanya O, Abiodun OO, Anya T, Tobechukwu I, Isiguzo G, Cheng HM, Chen CH, Liao CT, Mokwatsi G, Stolarz-Skrzypek K, Wojciechowska W, Narkiewicz K, Rajzer M, Brguljan-Hitij J, Nawrot TS, Asayama K, Reyskens P, Mischak H, Odili AN, Staessen JA; UPRIGHT-HTM Investigators.

Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial-First progress report.

J Clin Hypertens (Greenwich). 2023 Jun;25(6):521-533. doi: 10.1111/jch.14664. Epub 2023 May 6.

PMID: 37147930

View Abstract:  Free PMC article. Request Reprint

 

423.

De Beer D, Mels CMC, Schutte AE, Delles C, Mary S, Mullen W, Latosinska A, Mischak H, Kruger R.

Identifying a urinary peptidomics profile for hypertension in young adults: The African-PREDICT study: Urinary peptidomics and hypertension: Urinary peptidomics and hypertension.

Proteomics. 2023 Jun;23(11):e2200444. doi: 10.1002/pmic.202200444. Epub 2023 Apr 3.

PMID: 36943111

View Abstract:  Free PMC article. Request Reprint

 

422.

Devos H, Zoidakis J, Roubelakis MG, Latosinska A, Vlahou A.

Reviewing the Regulators of COL1A1.

Int J Mol Sci. 2023 Jun 11;24(12):10004. doi: 10.3390/ijms241210004.

PMID: 37373151

View Abstract:  Free PMC article. Request Reprint

 

421.

Catanese L, Siwy J, Mischak H, Wendt R, Beige J, Rupprecht H.

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.

Int J Mol Sci. 2023 May 23;24(11):9156. doi: 10.3390/ijms24119156.

PMID: 37298105

View Abstract:  Free PMC article. Request Reprint

 

420.

Davison BA, Edwards C, Cotter G, Kimmoun A, Gayat É, Latosinska A, Mischak H, Takagi K, Deniau B, Picod A, Mebazaa A.

Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU.

J Clin Med. 2023 May 6;12(9):3311. doi: 10.3390/jcm12093311.

PMID: 37176751

View Abstract:  Free PMC article. Request Reprint

 

419.

An DW, Yu YL, Martens DS, Latosinska A, Zhang ZY, Mischak H, Nawrot TS, Staessen JA.

Statistical approaches applicable in managing OMICS data: Urinary proteomics as exemplary case.

Mass Spectrom Rev. 2023 May 4. doi: 10.1002/mas.21849. Online ahead of print.

PMID: 37143314 

View Abstract:  Free PMC article. Request Reprint

 

418.

Degenaar A, Jacobs A, Kruger R, Delles C, Mischak H, Mels C.

Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study.

BMC Nephrol. 2023 Apr 13;24(1):96. doi: 10.1186/s12882-023-03100-w.

PMID: 37055746 

View Abstract:  Free PMC article. Request Reprint

 

417.

Rotbain Curovic V, Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Hansen TW, Havrdova T, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P; on the behalf of the PRIORITY Study Group.

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial.

J Diabetes Complications. 2023 Apr;37(4):108433. doi: 10.1016/j.jdiacomp.2023.108433. Epub 2023 Feb 18.

PMID: 36841085

View Abstract:  Free PMC article. Request Reprint

 

416.

Wei D, Melgarejo JD, Van Aelst L, Vanassche T, Verhamme P, Janssens S, Peter K, Zhang ZY.

Prediction of Coronary Artery Disease Using Urinary Proteomics.

Eur J Prev Cardiol. 2023 Mar 21:zwad087. doi: 10.1093/eurjpc/zwad087. Online ahead of print.

PMID: 36943304

View Abstract:  Free PMC article. Request Reprint

 

415.

Lohia S, Latosinska A, Zoidakis J, Makridakis M, Mischak H, Glorieux G, Vlahou A, Jankowski V.

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD.

Int J Mol Sci. 2023 Mar 11;24(6):5402. doi: 10.3390/ijms24065402.

PMID: 36982475

View Abstract:  Free PMC article. Request Reprint

 

414.

Massy ZA, Lambert O, Metzger M, Sedki M, Chaubet A, Breuil B, Jaafar A, Tack I, Nguyen-Khoa T, Alves M, Siwy J, Mischak H, Verbeke F, Glorieux G, Herpe YE, Schanstra JP, Stengel B, Klein J; CKD-REIN study group.

Machine Learning-Based Urine Peptidome Analysis to Predict and Understand Mechanisms of Progression to Kidney Failure.

Kidney Int Rep. 2022 Dec 12;8(3):544-555. doi: 10.1016/j.ekir.2022.11.023. eCollection 2023 Mar.

PMID: 36938091

View Abstract:  Free PMC article. Request Reprint

 

413.

Mokou M, Mischak H, Frantzi M.

Statistical determination of cancer biomarkers: moving forward clinically.

Expert Rev Mol Diagn. 2023 Mar;23(3):187-189. doi: 10.1080/14737159.2023.2187290. Epub 2023 Mar 6.

PMID: 36877119

View Abstract:  Free PMC article. Request Reprint

 

412.

Frantzi M, Culig Z, Heidegger I, Mokou M, Latosinska A, Roesch MC, Merseburger AS, Makridakis M, Vlahou A, Blanca-Pedregosa A, Carrasco-Valiente J, Mischak H, Gomez-Gomez E.

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.

Cancers (Basel). 2023 Feb 11;15(4):1166. doi: 10.3390/cancers15041166.

PMID: 36831508

View Abstract:  Free PMC article. Request Reprint

 

411.

de Beer D, Mels CMC, Schutte AE, Delles C, Mary S, Mullen W, Mischak H, Kruger R.

A urinary peptidomics approach for early stages of cardiovascular disease risk: The African-PREDICT study.

Hypertens Res. 2023 Feb;46(2):485-494. doi: 10.1038/s41440-022-01097-7. Epub 2022 Nov 17.

PMID: 36396816

View Abstract:  Free PMC article. Request Reprint

 

410.

Mokou M, Narayanasamy S, Stroggilos R, Balaur IA, Vlahou A, Mischak H, Frantzi M.

A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.

Methods Mol Biol. 2023;2684:59-99. doi: 10.1007/978-1-0716-3291-8_4.

PMID: 37410228

View Abstract:  Free PMC article. Request Reprint